跳至主要内容
临床试验/NCT05941910
NCT05941910招募中2 期

The Effect of 6-month Treatment With Coenzyme Q10 on Endothelial, Vascular and Myocardial Function in Patients With Non-alcoholic Fatty Liver Disease

Attikon Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
The effect of Q10 on Left Ventricular Myocardial Function

研究概览

简要总结

Non-alcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular risk. The aim of this study is to investigate the effects of coenzyme Q10 (CoQ10) on endothelial, vascular and myocardial function in patients with NAFLD

详细描述

Non-alcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular risk. The aim of this study is to investigate the effects of coenzyme Q10 (CoQ10) on endothelial, vascular and myocardial function in patients with NAFLD. In this trial patients with NAFLD will receive 240mg Q10 or placebo. At baseline and at 6 months, will be measured: a) Perfused boundary region (PBR) of the sublingual vessels using the SideviewDarkfieldimaging technique (Microscan, Glycocheck), b) pulse wave velocity (PWV-Complior, ALAM), c) flow-mediated dilation (FMD) of the brachial artery, d) left ventricular (LV) global longitudinal strain (GLS), and e) controlled attenuation parameter (CAP)for the quantification of liver steatosis by liver elastography (Fibroscan, Echosens).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • NAFLD AND one of below :
  • dyslipidemia, as it is defined in the metabolic syndrome
  • increased waist circumference as defined in the metabolic syndrome
  • Arterial hypertension,
  • overweight, (BMI>25)
  • polycystic ovary syndrome,

排除标准

  • Chronic Kidney Disease
  • Heart Failure
  • Liver failure
  • Pregnancy/ Breast feeding
  • Active malignancy (receiving Chemotherapy/immunotherapy)

研究组 & 干预措施

Q10

Active Comparator

干预措施: Q10 (Drug)

Placebo

Placebo Comparator

干预措施: Q10 (Drug)

结局指标

主要结局

The effect of Q10 on Left Ventricular Myocardial Function

时间窗: Six months

The effect of Q10 on Left Ventricular Global Longitudinal Strain after six month administration of Q10

次要结局

未报告次要终点

研究者

发起方
Attikon Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

VAIA LAMBADIARI

Professor of Internal Medicine-Endocrinology

Attikon Hospital

研究点 (1)

Loading locations...

相似试验